Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Moreton

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Occupational Medicine and Toxicology (London, England)|March 1, 2008
The effects of a graduated aerobic exercise programme on cardiovascular disease risk factors in the NHS workplace: a randomised controlled trialJennifer A Hewitt, Gregory P Whyte, Michelle Moreton, et al.
British Journal of Clinical Pharmacology|January 12, 2013
A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipientsOliver Boughton, Gabor Borgulya, Maurizio Cecconi, et al.
Transplantation|September 14, 2006
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirementsSalim Fredericks, Michelle Moreton, Sandrine Reboux, et al.
Transplantation|February 25, 2005
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South AsiansIain A M Macphee, Salim Fredericks, Maha Mohamed, et al.
Annals of Clinical Biochemistry|September 20, 2005
Genotyping cytochrome P450 3A5 using the Light CyclerSalim Fredericks, Michelle Moreton, Iain A M MacPhee, et al.
Clinical Transplantation|April 12, 2007
Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurementsSalim Fredericks, AnaMaria Jorga, Iain A M MacPhee, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Occupational Medicine and Toxicology (London, England)|March 1, 2008
The effects of a graduated aerobic exercise programme on cardiovascular disease risk factors in the NHS workplace: a randomised controlled trialJennifer A Hewitt, Gregory P Whyte, Michelle Moreton, et al.
British Journal of Clinical Pharmacology|January 12, 2013
A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipientsOliver Boughton, Gabor Borgulya, Maurizio Cecconi, et al.
Transplantation|September 14, 2006
Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirementsSalim Fredericks, Michelle Moreton, Sandrine Reboux, et al.
Transplantation|February 25, 2005
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South AsiansIain A M Macphee, Salim Fredericks, Maha Mohamed, et al.
Annals of Clinical Biochemistry|September 20, 2005
Genotyping cytochrome P450 3A5 using the Light CyclerSalim Fredericks, Michelle Moreton, Iain A M MacPhee, et al.
Clinical Transplantation|April 12, 2007
Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurementsSalim Fredericks, AnaMaria Jorga, Iain A M MacPhee, et al.
Pageof 1